期刊文献+
共找到741篇文章
< 1 2 38 >
每页显示 20 50 100
Using trace elements of magnetite to constrain the origin of the Pingchuan hydrothermal low-Ti magnetite deposit in the Panxi area, SW China 被引量:4
1
作者 Yanjun Wang Weiguang Zhu +3 位作者 Hong Zhong Zhongjie Bai Junhua Yao Chong Xu 《Acta Geochimica》 EI CAS CSCD 2019年第3期376-390,共15页
The Pingchuan iron deposit, located in the Yanyuan region of Sichuan Province, SW China, has an ore reserve of 40 Mt with ~60 wt% Fe. Its genesis is still poorly understood. The Pingchuan iron deposit has a parageneti... The Pingchuan iron deposit, located in the Yanyuan region of Sichuan Province, SW China, has an ore reserve of 40 Mt with ~60 wt% Fe. Its genesis is still poorly understood. The Pingchuan iron deposit has a paragenetic sequence of an early Fe-oxide–Pyrite stage(Ⅰ) and a late Fe-oxide–pyrrhotite stage(Ⅱ). Stage Ⅰ magnetite grains are generally fragmented, euhedral–subhedral, largesized crystals accompanying with slightly postdated pyrite.Stage Ⅱ magnetite grains are mostly unfragmented, anhedral, relatively small-sized grains that co-exist with pyrrhotite. Combined with micro-textural features and previously-obtained geochronological data, we consider that these two stages of iron mineralization in the Pingchuan deposit correspond to the Permian ELIP magmatism and Cenozoic fault activity event. Both the Stage Ⅰ and Ⅱ magnetites are characterized with overall lower contents of trace elements(including Cr, Ti, V, and Ni) than the ELIP magmatic magnetite, which suggests a hydrothermal origin for them. ‘‘Skarn-like'' enrichment in Sn, Mn, and Zn in the Stage Ⅰ magnetite grains indicate significant material contributions from carbonate wall-rocks due to water–rock interaction in ore-forming processes. Stage Ⅱ magnetite grains contain higher Mn concentrations than Stage Ⅰ magnetite grains, which possibly implies more contribution from carbonate rocks. In multiple-element diagrams, the Stage Ⅰ magnetite shows systematic similarities to Kiruna-type magnetite rather than those from other types of deposits. Combined with geological features and previous studies on oxygen isotopes, we conclude that hydrothermal fluids have played a key role in the generation of the Pingchuan low-Ti iron deposit. 展开更多
关键词 SW China pingchuan IRON DEPOSIT Low-Ti IRON DEPOSIT HYDROTHERMAL MAGNETITE
在线阅读 下载PDF
Pingchuan formula(平喘方) improves allergic asthma in mice through inhibiting nuclear factor-kappa B/mitogen-activated protein kinase signaling pathway 被引量:9
2
作者 WU Mingyun YU Jianer +7 位作者 BAI Li XUE Zheng JIANG Shenhua LI Liqing PIAO Xiang XU Wanchao WANG Jiani SHEN Qian 《Journal of Traditional Chinese Medicine》 SCIE CSCD 2021年第6期883-890,共8页
OBJECTIVE:To examine the role and decipher the mechanism of Pingchuan formula(平喘方,PCF)in treating allergic asthma.METHODS:The mice were treated with saline,dexamethasone(DXM)and PCF for 1 week after the asthma mode... OBJECTIVE:To examine the role and decipher the mechanism of Pingchuan formula(平喘方,PCF)in treating allergic asthma.METHODS:The mice were treated with saline,dexamethasone(DXM)and PCF for 1 week after the asthma model was established and their respiratory function including respiratory resistance(RI),pulmonary dynamic compliance(Cdyn)and maximum voluntary ventilation(MVV)were measured.In addition,cellular changes in bronchoalveolar lavage fluid(BALF)and pathological changes in lung biopsy as well as the expression level ofα-smooth muscle actin(α-SMA),transforming growth factor-beta1(TGF-β1)in BALF and interleukin-5(IL-5),interleukin-13(IL-13),tumor necrosis factor-α(TNF-α),interferon-γ(IFN-γ),nuclear factor-kappa B-p65(NF-κBp65),inhibitor-αof nuclear transcription factorκB(IκBα),p38 mitogen-activated protein kinase(p38 MAPK),c-jun n-terminal kinase(JNK)and its phosphorylated proteins in lung tissue were also examined and compared among different groups.RESULTS:Our data suggested that the respiratory functions were significantly improved and the pathological changes ameliorated in the DXM group and the PCF group compared to the model group.Both DXM and PCF effectively decreased the number of eosinophils,lymphocytes,and neutrophils in BAL as well as the secretion ofα-SMA and TGF-β1,IL-5,IL-13,while increased the expression of TNF-αand IFN-γ.Furthermore,our study indicated that the NF-κBp65,IκBα,p38 MAPK and JNK pathways were inhibited under the treatment of PCF.CONCLUSION:Our data indicated that PCF can attenuate the inflammatory response in asthma through inhibiting the NF-κB/MAPK signaling pathway.This study not only supported the use of PCF in allergic asthma in clinic but also shed light upon afurther understanding of the disease pathogenesis. 展开更多
关键词 ASTHMA NF-kappa B p38 mitogen-activated protein kinases signal transduction pingchuan formula
原文传递
Functional mechanism of Pingchuanning Decoction on adjustment of clara cell secretory protein in airway remodeling of asthmatic rats 被引量:5
3
作者 方向明 李俊 +1 位作者 李泽庚 董小波 《Journal of Traditional Chinese Medicine》 SCIE CAS CSCD 2012年第2期215-221,共7页
OBJECTIVE:To study the functional mechanism of Pingchuanning Decoction in treatment of airway remodeling in asthmatic rats.METHODS:Eighty healthy Wistar male rats were randomized into eight groups(n=10 rats each):Norm... OBJECTIVE:To study the functional mechanism of Pingchuanning Decoction in treatment of airway remodeling in asthmatic rats.METHODS:Eighty healthy Wistar male rats were randomized into eight groups(n=10 rats each):Normal group,Asthma model group,Dexamethasone group,Guilong Kechuanning group,Xiaoqinglong Decoction group,and Pingchuanning Decoction low-,middle-,and high-dose groups.The rats of all but the Normal group were made into asthma models through intraperitoneal injection and aerosol inhalation of ovalbumin.All treatments were administered at the first stimulation of asthma onset(third week of modeling),and the rats were killed after stimulating asthma attacks for 4 weeks.The general conditions of rats and pathomorphological changes of the lung tissues were observed.The expression of nerve growth factor(NGF) of the lung tissues was measured with immunohistochemical methods,and the content of Clara cell secretory protein(CCSP) mRNA was determined with RT-PCR.RESULTS:Compared with the Normal group,the contents of NGF and CCSP mRNA in the lung tissues of the Model group were significantly changed(P<0.01).Compared with the Model group,the indices of Pingchuanning Decoction and other treatment groups were improved to some extent(P<0.05 or P<0.01).CONCLUSIONS:Pathological changes of airway inflammation and remodeling were present in these rat asthma models.Pingchuanning Decoction had an intervention effect on these experimental models.Its functional mechanism may be related to multiple factors,including alleviation of airway inflammation,relief of bronchial smooth muscle spasm,and inhibition of airway remodeling. 展开更多
关键词 pingchuanning decoction Asthma Nerve growth factor Clara cell secretory protein Functional mechanism
原文传递
Untargeted serum metabonomic reveals alleviated ovalbumin-induced asthma by Baijin Pingchuan(白金平喘)through primary bile acid biosynthesis
4
作者 DING Lizhong ZHANG Qiang +3 位作者 SUN Yingying KONG Yibu SONG Yongfu WANG Yongji 《Journal of Traditional Chinese Medicine》 SCIE CSCD 2024年第6期1187-1193,共7页
OBJECTIVE: To investigate the effect of baijinpingchuan(白金平喘, BJPC) on the asthma rat model and identify differential metabolites and disturbed metabolic pathways. METHODS: The rats were categorized into six group... OBJECTIVE: To investigate the effect of baijinpingchuan(白金平喘, BJPC) on the asthma rat model and identify differential metabolites and disturbed metabolic pathways. METHODS: The rats were categorized into six groups: control, dexamethasone(DEX), ovalbumin(OVA), and low-, median-, and high-dose BJPC. The rats, except for the control group, were initially treated with OVA to develop the asthma model, which was then activated using DEX, OVA, and low-, median-, and high-dose BJPC. Enzyme-linked immunosorbent assay kit was used to detect the expression of interleukin(IL)-33, IL-25, thymic stromal lymphopoietin(TSLP), and transforming growth factor-beta 1(TGF-β1). Hematoxylin and eosin staining were performed to observe the pathological condition of the lung. Untargeted serum metabonomic analysis was conducted to identify differential metabolites and disturbed metabolic pathways. RESULTS: High-dose BJPC significantly inhibited the expression of IL-33, IL-25, TSLP, and TGF-β1(P < 0.0001). Further, high-dose BJPC improved inflammatory cell infiltration, which plays a similar role in asthma as DEX. OVA-induced and BJPC-treated rats were identified through 17 differential metabolites, especially cholic acid. Furthermore, primary bile acid biosynthesis was a significantly differential pathway in the mechanism of BJPC for treating asthma. CONCLUSIONS: BJPC plays an anti-inflammation role in asthma, which might be a promising therapy through mediating primary bile acid biosynthesis. 展开更多
关键词 ASTHMA OVALBUMIN untargeted serum metabonomic Baijin pingchuan
原文传递
Effect of Pingchuan granule on typeⅡinnate lymphocytes and M2 polarization of macrophages in asthmatic mice
5
作者 Yao Wang Xing-Xing Yuan +1 位作者 Chun-Yan Tian Zhu-Ying Li 《Journal of Hainan Medical University》 2021年第16期1-6,共6页
Objective:To observe the effect of Pingchuan granule on the number of typeⅡinnate lymphocytes(ILC2)and M2 polarization of macrophages in the lung tissue of asthmatic mice;Methods:Ovalbumin sensitized and challenged a... Objective:To observe the effect of Pingchuan granule on the number of typeⅡinnate lymphocytes(ILC2)and M2 polarization of macrophages in the lung tissue of asthmatic mice;Methods:Ovalbumin sensitized and challenged asthmatic mouse models were established,and then Pingchuan granules or IL-33 neutralizing antibody were given to intervene.The pathological morphology of lung tissue was observed by HE,PAS and Masson staining,and the expressions of IL-4,IL-5,IL-13 and IL-33 in BALF and lung tissue were detected by ELISA and qRT-PCR,Flow cytometry was used to detect the number of type II innate lymphocytes and type M2 macrophages in lung tissue.Western blot was used to detect the protein expression levels of ST-2,FIZZ1 and Arg-1 in lung tissue;Results:Compared with the control group,the inflammation score,PAS score and collagen staining area of the model group were significantly increased,the expressions of IL-4,IL-5,IL-13 and IL-33 in BALF and lung tissue were significantly increased,the number of ILC2 and M2 macrophages,the expression of ST-2,FIZZ1 and Arg-1 protein in lung tissue were significantly increased,and the differences were statistically significant(P<0.05);Compared with the model group,Pingchuan granule could significantly reduce the inflammation score,PAS score and collagen staining area of asthmatic mice,down-regulate the expression of IL-4,IL-5,IL-13 and IL-33 in BALF and lung tissue,reduce the number of ILC2 and M2 macrophages,and the expression of ST-2,FIZZ1 and Arg-1 protein in lung tissue(P<0.05);Conclusion:Pingchuan granule improve the airway remodeling of asthma by inhibiting the polarization of M2 macrophages mediated by ILC2. 展开更多
关键词 pingchuan granule Bronchial asthma Type II innate lymphocyte Macrophage M2 polarization
暂未订购
Clinical Study of Acupoint Application of Jiezi Fangxiao Ointment Combined with Pingchuan Prescription in the Treatment of Pediatric Asthma
6
作者 Yuzhe REN Zhou YU +2 位作者 Hong CHEN Zeyi YANG Xiangzheng YANG 《Medicinal Plant》 CAS 2021年第2期90-94,共5页
[Objectives]To study the clinical effect of Acupoint Application of Jiezi Fangxiao Ointment combined with Pingchuan Prescription in the treatment of pediatric asthma.[Methods]A total of 40 children with asthma admitte... [Objectives]To study the clinical effect of Acupoint Application of Jiezi Fangxiao Ointment combined with Pingchuan Prescription in the treatment of pediatric asthma.[Methods]A total of 40 children with asthma admitted to the First Affiliated Hospital of Heilongjiang University of Chinese Medicine from July 2017 to September 2018 were selected as the research subjects,and divided into control group and observation group according to random classification method,with 20 cases in each group.Among which the control group was given routine symptomatic treatment,the observation group was treated with Acupoint Application of Jiezi Fangxiao Ointment combined with Pingchuan Prescription on the basis of the control group.After 4 weeks of continuous treatment,the clinical efficacy was observed and the changes of traditional Chinese medicine symptom scores,forced expiratory volume in the first second(FEV1),maximum expiratory flow(PEF),forced vital capacity(FVC),peripheral blood eosinophils(EOS)and interleukin-17(IL-17)were compared between the two groups before and after treatment.[Results]After treatment,the traditional Chinese medicine(TCM)scores such as asthma,cough,expectoration,chest tightness,dyspnea and wheezing sound of lungs in the two groups were significantly improved,and the improvement in the observation group was superior to that in the control group.The difference was statistically significant(P<0.05).FEV1,PEF and FVC in the two groups were significantly improved after treatment,and the improvement in the observation group was superior to that in the control group.The difference was statistically significant(P<0.05);after treatment,the levels of EOS and IL-17 decreased in both groups,and the improvement in the observation group was superior to that in the control group,the difference was statistically significant(P<0.05).[Conclusions]The clinical effects of Acupoint Application of Jiezi Fangxiao Ointment combined with Pingchuan Prescription in the treatment of infantile asthma were obvious,which can significantly improve the TCM symptoms scores,pulmonary function and immune function of patients. 展开更多
关键词 Pediatric asthma Acupoint Application of Jiezi Fangxiao Ointment pingchuan Prescription Traditional Chinese medicine syndrome scores Lung function Peripheral blood eosinophils INTERLEUKIN-17 Clinical research
暂未订购
Clinical Observation of Huagai Pingchuan Decoction Combined with Seretide in the Treatment of Asthma
7
作者 Rong He 《Proceedings of Anticancer Research》 2020年第5期25-28,共4页
Objective:To study the clinical effect of the Huagai Pingchuan decoction combined with Seretide in the treatment of asthma.Methods:138 cases of asthma patients in our hospital were separated into the control group and... Objective:To study the clinical effect of the Huagai Pingchuan decoction combined with Seretide in the treatment of asthma.Methods:138 cases of asthma patients in our hospital were separated into the control group and the experimental group.The control group was given Seretide alone,while the experimental group was treated with Huagai Pingchuan decoction combined with Seretide.Results:After treatment,the wheezing symptoms remission time of the experimental group was shorter than control group,the performance of serum inflammatory factors and lung function indexes were better than control group,P<0.05 with significant difference.Conclusion:Huagai Pingchuan decoction combined with Seretide is more effec-tive in the treatment of asthma. 展开更多
关键词 Huagai pingchuan decoction SERETIDE ASTHMA
暂未订购
Randomized Controlled Trial on Treatment of Bronchial Asthma of Qi-deficiency Cold Syndrome Type by Pingchuan Yiqi Granule (平喘益气颗粒) 被引量:3
8
作者 张颖 常静 +6 位作者 迟焕海 毛兵 唐文富 王蕾 黄素珍 李廷谦 张瑞明 《Chinese Journal of Integrative Medicine》 SCIE CAS 2007年第1期27-32,共6页
Objective: To evaluate the effect and safety of Pingchuan Yiqi Granule (平喘益气颗粒, PYG) in treating bronchial asthma of qi-deficiency cold syndrome type (BS-QDC). Methods: With the randomized, positive agent ... Objective: To evaluate the effect and safety of Pingchuan Yiqi Granule (平喘益气颗粒, PYG) in treating bronchial asthma of qi-deficiency cold syndrome type (BS-QDC). Methods: With the randomized, positive agent parallel controlled design adopted, the 80 subjects enrolled were assigned in the ratio of 3:1 to two groups, the 60 patients in the trial group were treated with PYG and the 20 in the control group treated with Ruyi Dingchuan Pill (如意定喘丸,RDP), with the therapeutic course consisting of 7 days for both groups. The clinical effects, effects on TCM syndrome and the changes of lung function after treatment were observed. Results: The effect of the treatment on asthma in the trial group: clinically controlled rate was 6.67%, markedly effective rate 51.67%, improved rate 33.33% and ineffective rate 8.33%; and the corresponding rates in the control group were 5.00%, 50.00%, 30.00%, and 15.00% respectively. Comparison between the two groups showed insignificant difference (P〉0.05). The effect on TCM syndrome in the treated group: clinically controlled rate was 11.67%, markedly effective rate 58.33%, effective rate 21.67% and ineffective rate 8.33%; and those in the control group were 10.00%, 50.00%, 30.00% and 10.00% respectively, also showing insignificant difference between the two groups (P〉0.05). Lung function test showed that the change on forced expiratory volume in 1 second (FEV1) after treatment in the trial group was of statistical significance (P〈0.05), but no significant difference was shown in the change of peak expiratory flow (PEE P〉0.05); while the changes in the control group were just the opposite, showing insignificance in FEV1 (P〉0.05) but significance in PEF (P〈0.05). Comparison of the therapeutic effect on lung function between the two groups showed no significant difference (P〉0.05). No adverse reaction was found in either group in the course of treatment. Conclusion: PYG used to treat BS-QDC is effective and safe, it's effect is similar to that of RDP. 展开更多
关键词 pingchuan Yiqi Granule randomized controlled trial bronchial asthma qi-deficiency cold syndrome type
原文传递
化痰平喘方辅助多索茶碱治疗支气管哮喘急性发作的临床观察
9
作者 田亚楠 《四川生理科学杂志》 2026年第1期104-106,110,共4页
目的:观察化痰平喘方辅助多索茶碱治疗支气管哮喘(Bronchial Asthma,BA)急性发作的临床疗效。方法:选取2023年2月至2024年4月期间郑州市中医院确诊BA患者116例,均为急性发作来院就诊,采用随机数字表法将患者分为观察组和对照组,各58例... 目的:观察化痰平喘方辅助多索茶碱治疗支气管哮喘(Bronchial Asthma,BA)急性发作的临床疗效。方法:选取2023年2月至2024年4月期间郑州市中医院确诊BA患者116例,均为急性发作来院就诊,采用随机数字表法将患者分为观察组和对照组,各58例。全部患者均接受常规对症支持治疗,并予多索茶碱治疗,观察组在此基础上使用化痰平喘方辅助治疗。持续治疗7 d后评估并比较两组疗效,分别于治疗前后,比较两组中医症状积分、肺功能(用力肺活量(Forced vital capacity,FVC)、呼气峰值流速(Peak expiratory flow rate,PEF))、炎性因子(白细胞介素-6(Interleukin-6,IL-6)、白细胞介素-8(Interleukin 8,IL-8)、γ-干扰素(Interferon-γ,IFN-γ)),统计不良反应。结果:观察组治疗总有效率高于对照组(P<0.05)。治疗7 d,观察组中医症状积分低于对照组,FVC、FEV1、PEF水平高于对照组,IL-6、IL-8、IFN-γ水平低于对照组。组间不良反应发生率对比无差异(P>0.05)。结论:化痰平喘方辅助多索茶碱治疗BA急性发作,能提高疗效,显著改善患者肺功能,促进症状缓解,且安全性好。 展开更多
关键词 支气管哮喘 化痰平喘方 多索茶碱 疗效 安全性
暂未订购
宣肺平喘方联合布地奈德治疗慢性阻塞性肺疾病急性加重期患者的效果
10
作者 周莹莹 张乐 《西北药学杂志》 2026年第1期160-166,共7页
目的探究宣肺平喘方联合布地奈德治疗慢性阻塞性肺疾病急性加重期(acute exacerbation of chronic obstructive pulmonary disease,AECOPD)患者的效果,及对患者中医证候、膈肌功能及炎症反应调控的影响。方法该研究为前瞻性随机对照试... 目的探究宣肺平喘方联合布地奈德治疗慢性阻塞性肺疾病急性加重期(acute exacerbation of chronic obstructive pulmonary disease,AECOPD)患者的效果,及对患者中医证候、膈肌功能及炎症反应调控的影响。方法该研究为前瞻性随机对照试验。选取黄河三门峡医院2021年10月—2024年1月收治的AECOPD患者137例作为研究对象,因中途退出研究5例,故最终纳入132例进行研究,用随机数字表法将纳入的患者分为对照组(给予常规对症和布地奈德福莫特罗粉吸入剂雾化吸入治疗)和试验组(在对照组治疗的基础上联合宣肺平喘方治疗),每组66例。2组均治疗1个月。比较2组的疗效和治疗前、治疗1个月后的肺功能、中医证候积分、膈肌功能、T淋巴细胞亚群、炎症反应指标水平及治疗期间不良反应的发生情况。结果试验组治疗1个月后的总有效率(93.94%)高于对照组(78.79%),P<0.05。治疗1个月后,2组的峰值呼气流速(peak expiratory flow,PEF)、第1秒用力呼气容积(forced expiratory volume in one second,FEV_(1))、用力肺活量(forced vital capacity,FVC)、FEV_(1)/FVC均升高,且试验组均高于对照组(P<0.05)。治疗1个月后,2组的咳喘、咳白痰、痰多痰鸣、胸闷评分均降低,且试验组均低于对照组(P<0.05)。治疗1个月后,2组的膈肌增厚分数、膈肌收缩强度均升高,且试验组均高于对照组;2组的平静呼吸膈肌移动度、膈肌浅快呼吸指数、膈肌收缩速率均降低,且试验组均低于对照组(P<0.05)。治疗1个月后,2组的全血CD8^(+)均降低,且试验组低于对照组;2组的全血CD4^(+)、CD4^(+)/CD8^(+)均升高,且试验组均高于对照组(P<0.05)。治疗1个月后,2组的血清降钙素原(procalcitonin,PCT)、白细胞介素-17(interleukin-17,IL-17)、超敏C反应蛋白(high-sensitivity C-reactive protein,hs-CRP)及肿瘤坏死因子-α(tumor necrosis factor-α,TNF-α)水平均降低,且试验组均低于对照组(P<0.05)。试验组治疗期间的不良反应总发生率为6.06%,低于对照组的18.18%,P<0.05。结论宣肺平喘方联合布地奈德治疗AECOPD的疗效和安全性均较好,可能与该治疗方案能够调节患者机体T淋巴细胞亚群和炎症反应,改善患者中医证候、膈肌功能及肺功能有关。 展开更多
关键词 慢性阻塞性肺疾病急性加重期 宣肺平喘方 布地奈德 中医证候 膈肌功能 炎症反应
暂未订购
平喘宁方通过调控HMGB1/Beclin-1轴介导的自噬改善患寒哮证大鼠的气道炎症 被引量:1
11
作者 王心恒 邵小涵 +6 位作者 李童童 张璐 杨勤军 叶卫东 童佳兵 李泽庚 方向明 《南方医科大学学报》 北大核心 2025年第6期1153-1162,共10页
目的 基于高迁移率族蛋白B1(HMGB1)/自噬相关基因Beclin-1(Beclin-1)轴探讨平喘宁方(PCN)调控细胞自噬减轻寒哮证大鼠气道炎症的作用。方法 105只SPF级SD大鼠,随机分为对照组(CON)、模型组(MOD)、平喘宁高、中、低剂量组(PCN-H、PCN-M、... 目的 基于高迁移率族蛋白B1(HMGB1)/自噬相关基因Beclin-1(Beclin-1)轴探讨平喘宁方(PCN)调控细胞自噬减轻寒哮证大鼠气道炎症的作用。方法 105只SPF级SD大鼠,随机分为对照组(CON)、模型组(MOD)、平喘宁高、中、低剂量组(PCN-H、PCN-M、PCN-L)、桂龙咳喘宁组(GLCKN)和地塞米松组(DEX),15只/组。除CON组外,其余大鼠构建寒哮证模型,并从第29天开始灌胃PCN、DEX及GLCKN。观察各组大鼠体质量、摄食量、摄水量,肺功能、肺组织氧化应激水平、肺泡灌洗液(BALF)炎性因子、肺组织病理、肺组织超微结构,细胞因子水平以及HMGB1/Beclin-1信号轴和细胞自噬相关基因和蛋白的表达。结果 与CON组比较,MOD组大鼠表现出呼吸急促、喘息、流涕、腹部收缩明显、反应迟钝、反应缓慢,进食量减少,明显的皮毛枯槁或脱落等表现;体质量、摄食量、摄水量明显下降(P<0.05);第0.3秒用力呼气量(FEV0.3)、用力肺活量(FVC)、FEV0.3/FVC明显降低(P<0.05);肺组织表现出明显的炎性浸润,肺泡炎症评分明显上升(P<0.05);BALF中性粒细胞、嗜酸性粒细胞、淋巴细胞、巨噬细胞、白细胞数量明显上升(P<0.05);肺组织MDA明显上升,SOD明显下降(P<0.05);透射电镜(TEM)观察发现MOD组有自噬小泡数量较多,线粒体排列有紊乱及水肿现象,嗜锇性板层小体排空比较明显;肺组织HMGB1、Beclin-1、ATG5蛋白及mRNA表达明显上升,Bcl-2蛋白表达及mRNA明显降低,LC3II/I比值明显上升(P<0.05);大鼠肺组织细胞因子IFN-γ明显降低,TNF-α、IL-6IL-1β、IL-13明显上升(P<0.05)。与MOD组比较,PCN能明显改善各项指标的病理改变,且作用效果优于GLKCN组,不亚于DEX组(P<0.05)。结论 PCN能有效改善寒哮证模型大鼠气道炎症,其机制可能与调控HMGB1/Beclin-1信号轴,抑制细胞自噬从而缓解炎症损伤有关。 展开更多
关键词 支气管哮喘 平喘宁方 细胞自噬 肺功能 气道炎症 寒哮证
暂未订购
止咳平喘十二味合剂治疗痰热型哮喘-慢阻肺重叠临床研究 被引量:1
12
作者 洪儿 陶伟 +2 位作者 鲍翊君 陈希尔 俞亚丽 《新中医》 2025年第4期31-35,共5页
目的:观察止咳平喘十二味合剂治疗痰热型哮喘-慢阻肺重叠(ACO)的临床疗效。方法:将2020年9月—2023年10月于浙江中医药大学附属宁波市中医院就诊的88例ACO患者,按随机数字表法分为对照组和治疗组各44例。对照组采用布地奈德福莫特罗吸... 目的:观察止咳平喘十二味合剂治疗痰热型哮喘-慢阻肺重叠(ACO)的临床疗效。方法:将2020年9月—2023年10月于浙江中医药大学附属宁波市中医院就诊的88例ACO患者,按随机数字表法分为对照组和治疗组各44例。对照组采用布地奈德福莫特罗吸入粉雾剂(Ⅱ)治疗,治疗组在对照组基础上联合止咳平喘十二味合剂治疗,疗程均为4周。比较2组治疗前后慢性阻塞性肺疾病评估测试(CAT)和哮喘控制测试(ACT)、6 min步行距离(6MWT)、呼出气一氧化氮(Fe NO)、肺功能指标[第1秒用力呼气量(FEV_(1))、呼气峰值流速(PEF)、用力呼气中期流速(MMEF_(75/25))]及外周血嗜酸性粒细胞计数(EOS)、免疫球蛋白E(Ig E)、白细胞介素-5(IL-5)水平变化。结果:治疗后,2组CAT评分均较治疗前降低(P<0.05),ACT评分均较治疗前上升(P<0.05);且治疗组CAT评分低于对照组(P<0.05),ACT评分高于对照组(P<0.05)。治疗后,2组6MWT均较治疗前增加(P<0.05),且治疗组6MWT大于对照组(P<0.05)。治疗后,2组FEV_(1)、PEF及MMEF_(75/25)水平均较前增加(P<0.05),且治疗组FEV_(1)、PEF及MMEF_(75/25)水平均高于对照组(P<0.05)。治疗后,2组Fe NO水平均较治疗前降低(P<0.05),且治疗组Fe NO水平低于对照组(P<0.05)。治疗后,2组外周血EOS、Ig E、IL-5水平均较治疗前降低(P<0.05),且治疗组外周血EOS、Ig E、IL-5水平低于对照组(P<0.05)。结论:止咳平喘十二味合剂可抑制气道炎症反应,降低外周血炎症介质水平,减轻ACO患者的临床症状,提高活动耐力,改善生活质量和肺通气功能。 展开更多
关键词 哮喘-慢阻肺重叠 止咳平喘十二味合剂 白细胞介素-5 免疫球蛋白E
原文传递
肃肺平喘方治疗支气管扩张症合并气流受限痰热蕴肺兼肺脾气虚证患者的随机对照试验
13
作者 袁沙沙 张海艳 +3 位作者 石霞 王冰 丛晓东 苗青 《中医杂志》 北大核心 2025年第6期581-587,共7页
目的评价肃肺平喘方治疗支气管扩张症(简称支扩)合并气流受限痰热蕴肺兼肺脾气虚证患者的有效性及安全性。方法采用随机、双盲、安慰剂对照试验方案,将72例稳定期支扩合并气流受限的痰热蕴肺兼肺脾气虚证患者随机分为治疗组和对照组各3... 目的评价肃肺平喘方治疗支气管扩张症(简称支扩)合并气流受限痰热蕴肺兼肺脾气虚证患者的有效性及安全性。方法采用随机、双盲、安慰剂对照试验方案,将72例稳定期支扩合并气流受限的痰热蕴肺兼肺脾气虚证患者随机分为治疗组和对照组各36例。两组患者在规律使用噻托溴铵吸入喷雾剂的基础上,治疗组给予肃肺平喘方颗粒剂,对照组给予肃肺平喘方颗粒剂模拟剂,两组疗程均为12周。分别观察两组患者治疗前后肺功能第一秒用力呼气容积(FEV1);分别于治疗前及治疗4、8、12周后观察两组患者改良版英国医学研究委员会呼吸困难量表(mMRC)、24小时痰量、慢性阻塞性肺病评估测试(CAT)、中医证候积分;于治疗4、8、12周后统计两组患者急性加重情况;记录两组患者治疗前后血常规、尿常规、肝肾功能等变化及不良事件的发生情况。结果治疗后治疗组脱落4例,对照组脱落6例。治疗12周后两组FEV1均较治疗前升高(P<0.05),但治疗后组间比较差异无统计学意义(P>0.05)。与治疗前比较,治疗组在治疗12周后mMRC评分降低(P<0.05),在治疗4、8、12周后24小时痰量、CAT评分、中医证候积分均降低(P<0.05);对照组在治疗12周后24小时痰量降低(P<0.05),在治疗8、12周后中医证候积分均降低(P<0.05)。与对照组比较,治疗组在治疗12周后mMRC降低(P<0.05),在治疗4、8、12周后24小时痰量、中医证候积分均降低(P<0.05),在治疗8、12周后CAT评分降低(P<0.05)。治疗组的急性加重例次及急性加重次数在治疗12周后均低于对照组(P<0.05)。两组患者均未发生严重不良事件。结论肃肺平喘方可以改善支扩合并气流受限患者的肺功能FEV1、呼吸困难严重程度,减少24小时痰量和频繁急性加重,并改善生活质量,且安全性较好。 展开更多
关键词 支气管扩张症 气流受限 肃肺平喘方 肺功能 黏液高分泌
原文传递
祛痰降逆平喘方联合复方异丙托溴铵对慢性阻塞性肺疾病急性加重期患者的临床疗效
14
作者 张娜娜 石芳 +3 位作者 贾琳 郭烁 郭洁 张萱 《中成药》 北大核心 2025年第8期2572-2576,共5页
目的探讨祛痰降逆平喘方联合复方异丙托溴铵对慢性阻塞性肺疾病急性加重期患者的临床疗效。方法110例患者随机分为对照组和观察组,每组55例,2组采用常规治疗,同时对照组给予复方异丙托溴铵,观察组在对照组基础上加用祛痰降逆平喘方,疗程... 目的探讨祛痰降逆平喘方联合复方异丙托溴铵对慢性阻塞性肺疾病急性加重期患者的临床疗效。方法110例患者随机分为对照组和观察组,每组55例,2组采用常规治疗,同时对照组给予复方异丙托溴铵,观察组在对照组基础上加用祛痰降逆平喘方,疗程2周。检测临床疗效、相关评分(中医证候评分、mMRC分级、CAT评分)、临床症状(咳嗽、喘息、肺哮鸣音)消失时间、气道炎症指标(sICAM-1、IL-8、MCP-1)、肺功能指标(FEV_(1)、PEF25、TLC)、痰液指标(24 h痰量、痰液黏稠度)、不良反应发生率变化。结果观察组总有效率高于对照组(P<0.05),临床症状消失时间更短(P<0.05)。治疗后,2组相关评分、气道炎症指标、24 h痰量降低(P<0.05),肺功能指标升高(P<0.05),以观察组更明显(P<0.05);观察组痰液黏稠度Ⅰ级人数增加(P<0.05),比对照组更明显(P<0.05)。2组不良反应发生率比较,差异无统计学意义(P>0.05)。结论祛痰降逆平喘方联合复方异丙托溴铵可安全有效地改善慢性阻塞性肺疾病急性加重期患者临床症状,降低炎症水平,提高肺功能,促进气道内痰液分泌。 展开更多
关键词 祛痰降逆平喘方 复方异丙托溴铵 慢性阻塞性肺疾病 急性加重期
暂未订购
六君子汤联合清咳平喘颗粒治疗尘肺病的临床研究
15
作者 邱梦茹 贺今 +1 位作者 周曦 沈宁 《药物评价研究》 北大核心 2025年第5期1301-1307,共7页
目的分析探讨在西医治疗基础上,清咳平喘颗粒单用及与六君子汤联用治疗尘肺病的临床疗效。方法将2022年1月—2023年12月山东第一医科大学附属职业病医院收治的138例气虚质尘肺病患者按随机数字表分为对照组、清咳平喘颗粒(清咳)组、清... 目的分析探讨在西医治疗基础上,清咳平喘颗粒单用及与六君子汤联用治疗尘肺病的临床疗效。方法将2022年1月—2023年12月山东第一医科大学附属职业病医院收治的138例气虚质尘肺病患者按随机数字表分为对照组、清咳平喘颗粒(清咳)组、清咳平喘颗粒+六君子汤联合组,每组各46例。对照组以西医综合治疗,清咳组在西医基础治疗的基础上,加用清咳平喘颗粒治疗,联合组在清咳组治疗的基础上联合六君子汤治疗。对比3组临床疗效、中医证候、肺功能水平[用力肺活量(FVC)、最大呼气中期流量(MMEF)、第一秒用力呼气容积占用力肺活量百分比(FEV1/FVC)]、疾病康复指标[血氧饱和度(SpO_(2))、慢性阻塞性肺病疾病评分(CAT)、急性发作次数]、呼出气一氧化氮(FeNO)、降钙素原、治疗安全性。结果清咳组、联合组总有效率均高于对照组(P<0.05),均能显著降低中医证候积分,提高SpO_(2)水平,降低CAT评分、急性发作次数、FeNO及降钙素原水平(P<0.05)。其中联合组在改善患者神疲乏力、气短懒言状态,提升肺功能水平,促进疾病康复指标恢复,降低降钙素原方面显著强于清咳组(P<0.05)。3组不良反应发生率比较无差异性(P>0.05)。结论在西医基础治疗的基础上,清咳平喘颗粒治疗尘肺病有良好效果,能显著提升治疗有效率,减轻中医证候程度,提高肺功能水平,促进疾病的康复状态,提高血氧饱和度,降低CAT评分,减少急性发作次数,减轻炎症水平,安全性好,可推荐用于尘肺病的治疗。在此基础上,联合使用六君子汤,可进一步提升其治疗效果。 展开更多
关键词 尘肺病 清咳平喘颗粒 六君子汤 疗效 中医证候 肺功能 肺纤维化
原文传递
四川矿山梁子苦橄玢岩成因:来自橄榄石成分剖面的约束
16
作者 罗照华 《地学前缘》 北大核心 2025年第6期286-302,共17页
苦橄岩通常作为地幔柱活动的证据之一,得到了众多学者的关注。然而,许多苦橄岩中含有不同结晶习性的橄榄石晶体,暗示了外来橄榄石晶体的加入。因此,阐明苦橄岩中橄榄石晶体的性质是理解苦橄岩成因及其地质意义的关键环节。本文报道了川... 苦橄岩通常作为地幔柱活动的证据之一,得到了众多学者的关注。然而,许多苦橄岩中含有不同结晶习性的橄榄石晶体,暗示了外来橄榄石晶体的加入。因此,阐明苦橄岩中橄榄石晶体的性质是理解苦橄岩成因及其地质意义的关键环节。本文报道了川西矿山梁子苦橄玢岩岩席中代表性橄榄石颗粒的成分剖面分析结果,发现苦橄玢岩含有4类橄榄石晶体,分别将其称为粗晶橄榄石、聚斑状橄榄石、包裹体橄榄石和鬣刺状橄榄石。统计分析表明粗晶橄榄石具有一个Fo_(84)的主要峰值和一个Fo_(77)的次要峰值;聚斑状橄榄石具有一个Fo_(92)的主要峰值和一个Fo_(77)的次要峰值;包裹体橄榄石(Fo_(82))和鬣刺状橄榄石(Fo_(77))只有一个峰值,其中包裹体橄榄石具有均一的成分,而鬣刺状橄榄石具有陡的成分梯度。将成分相近的粗晶橄榄石和包裹体橄榄石合并,则矿山梁子苦橄玢岩中包含3种Fo分布范围明显不同的橄榄石晶体群。这3种晶体群也产于峨眉山玄武岩和大板山辉长岩中,因而可以认为岩浆混合作用是峨眉山大火成岩省岩浆系统的遍在性岩浆过程。热力学和流体动力学分析揭示,聚斑状橄榄石形成于约4 GPa和约1600℃,粗晶橄榄石(及包裹体橄榄石)主要形成于约2~2.5 GPa和约1450~1550℃,而鬣刺状橄榄石形成于约0.1 GPa和约1200℃。据此,可以认为鬣刺状橄榄石形成于携带岩浆的结晶作用,另两类橄榄石则是携带岩浆从深部岩浆房中捕获的循环晶(antecryst)。橄榄石的NiO含量总体随Fo增加而增加,但存在4个不同的次级变异趋势,其特点是Fo值增加不大的背景下NiO含量急剧升高,暗示岩浆为挥发分流体过饱和系统。此外,样品的橄榄石体积分数随高程强烈变化,与聚斑状橄榄石的产出一起,暗示了岩浆的快速运动。据此,本文认为矿山梁子岩浆系统为至少具有3个深部岩浆房的系统,苦橄玢岩是熔体、晶体和流体的混合物,而不是原生苦橄质岩浆固结的产物。 展开更多
关键词 平川铁矿 苦橄质岩床 橄榄石晶体群 透岩浆流体 攀枝花式铁矿
在线阅读 下载PDF
清咳平喘颗粒治疗支气管扩张症的回顾性临床研究 被引量:1
17
作者 樊雅欣 柏萍 +6 位作者 王钰 马双双 张晔敏 毕蓉蓉 吴定中 张惠勇 邱磊 《中草药》 北大核心 2025年第9期3197-3202,共6页
目的 探讨清咳平喘颗粒联合西医常规方案治疗支气管扩张症的疗效及对患者出院后再次急性加重的影响。方法选取2021年2月—2023年6月在上海中医药大学附属龙华医院肺病科出院的122例支气管扩张症患者进行回顾性分析,按治疗方案不同将其... 目的 探讨清咳平喘颗粒联合西医常规方案治疗支气管扩张症的疗效及对患者出院后再次急性加重的影响。方法选取2021年2月—2023年6月在上海中医药大学附属龙华医院肺病科出院的122例支气管扩张症患者进行回顾性分析,按治疗方案不同将其分为治疗组61例和对照组61例。对照组出院后仅接受西医常规治疗方案,疗程为1周;治疗组在对照组基础上联合清咳平喘颗粒治疗,疗程为8周。以患者出院为起点随访24周,对比两组出院后24周内出现的急性加重比例,基线(出院第1天)及入组24周后圣乔治呼吸问卷(St. George’s respiratory questionnaire,SGRQ)评分、肺功能指标并记录不良事件。结果 治疗组总有效率为65.6%,对照组总有效率为44.3%,差异具有统计学意义(P<0.05)。出院后24周内,治疗组的急性加重比例明显低于对照组(19.7%vs 36.1%,P<0.05);与对照组相比,治疗组再次出现急性加重的时间[(137.23±57.14)d vs(157.18±44.07)d]延长(P<0.05)。入组24周后,两组SGRQ评分(症状、活动、心理评分和总分)均较基线显著降低(P<0.05);治疗组SGRQ活动评分改善值显著高于对照组(P<0.05);两组肺功能指标[第1秒用力呼气容积(Forced expiratory volume for 1 second,FEV1)、用力肺活量(forced vital capacity,FVC)、FEV1/FVC]均较基线升高,但差异无统计学意义(P>0.05),治疗组肺功能指标改善值与对照组比较差异无统计学意义(P>0.05)。两组总不良反应发生率差异无统计学意义(P>0.05)。结论 清咳平喘颗粒联合西医常规方案能够有效降低支气管扩张症患者出院后24周内再次急性加重风险,助力改善慢性呼吸道症状及活动能力,且具有较好的安全性。 展开更多
关键词 支气管扩张症 急性加重 清咳平喘颗粒 中成药 圣乔治呼吸问卷评分 肺功能
原文传递
麻芍平喘方治疗支气管哮喘的作用机制探讨 被引量:2
18
作者 吴蓓 方莉 杨程 《中医药临床杂志》 2025年第4期719-726,共8页
目的:该研究旨在利用网络药理学方法探究麻芍平喘方对支气管哮喘的作用机制。方法:利用TC.MSP、Pubchem、Swiss target prediction等数据库平台,检索、收集和筛选麻芍平喘方的有效活性成分和有效靶点基因。利用Genecards、Disgenet、OMI... 目的:该研究旨在利用网络药理学方法探究麻芍平喘方对支气管哮喘的作用机制。方法:利用TC.MSP、Pubchem、Swiss target prediction等数据库平台,检索、收集和筛选麻芍平喘方的有效活性成分和有效靶点基因。利用Genecards、Disgenet、OMIM数据库查询相关基因和麻芍平喘方治疗支气管哮喘的交集靶点。接着,将活性成分和靶点构建成可视化网络,利用STRING数据库和Cytoscape3.9.1软件进行相关分析。此外,使用metascape数据库进行基因本体(GO)功能和京都基因与基因组百科全书(KEGG)通路的富集分析。最后通过分子对接实验验证分析得到的结果。研究结果表明成功筛选出了62种麻芍平喘方的活性成分和232个药物靶点,同时涉及了20210个疾病靶点和229个交集靶点。在对关键靶点进行蛋白质-蛋白质互作(PPI)网络构建时,发现涉及了18个主要基因。GO功能富集分析共得到959个条目,其中包括754个生物过程条目、75个分子功能条目、以及130个细胞条目。而KEGG通路富集分析则揭示了178条信号通路。结论:麻芍平喘方的多种成分可以通过多条途径作用于多个靶点来治疗支气管哮喘。对分析得到的六种潜在功能化合物与支气管哮喘炎症通路关键靶点白细胞介素-6、肿瘤坏死因子进行分子对接实验发现它们均有着极强的结合能力。 展开更多
关键词 麻芍平喘方 支气管哮喘 网络药理学 分子对接
暂未订购
基于TLR4/MyD88/NF-κB信号通路研究平喘颗粒对咳嗽变异性哮喘小鼠气道炎症的作用机制 被引量:1
19
作者 肖靖 王彤 +1 位作者 吴虹润 崔瑞琴 《海南医科大学学报》 北大核心 2025年第11期833-839,共7页
目的:通过研究咳嗽变异性哮喘(CVA)模型小鼠肺组织的TLR4、MyD88和NF-κB表达来探讨平喘颗粒减轻CVA气道炎症的作用机制。方法:将60只小鼠按照数字表法随机分成空白组、模型组、平喘颗粒组以及阳性对照组(孟鲁司特钠组)。腹腔注射致敏液... 目的:通过研究咳嗽变异性哮喘(CVA)模型小鼠肺组织的TLR4、MyD88和NF-κB表达来探讨平喘颗粒减轻CVA气道炎症的作用机制。方法:将60只小鼠按照数字表法随机分成空白组、模型组、平喘颗粒组以及阳性对照组(孟鲁司特钠组)。腹腔注射致敏液(鸡蛋清白蛋白100μg+氢氧化铝20μg)联合雾化激发(1.5%鸡蛋清白蛋白)制备CVA模型。在雾化激发的同时不同分组对应予以平喘颗粒、孟鲁司特钠、生理盐水灌胃。采用H&E染色法对小鼠肺组织形态进行观察,酶联免疫吸附试验检测小鼠血清中IL-4、IL-13含量,免疫组化染色法检测TLR4和NF-κB蛋白表达情况,免疫印迹法检测小鼠肺组织中TLR4、MyD88以及NF-κB蛋白的表达量。结果:与空白组对比,模型组小鼠肺组织中可见炎性细胞浸润较多,支气管壁结构不完整,上皮部位增厚,肺泡明显扩张;TLR4、MyD88、NF-κB蛋白相对表达量在小鼠肺组织中均显著升高(P<0.05,P<0.001);IL-4、IL-13含量在小鼠血清中明显升高(P<0.001)。与模型组对比,平喘颗粒组和阳性对照组肺组织中可见炎性细胞浸润减少,上皮部位厚度减少,支气管壁结构形态完整;肺组织中NF-κB、MyD88和TLR4的蛋白表达明显下调(P<0.05,P<0.01);小鼠血清中炎症因子IL-4和IL-13水平下调明显(P<0.05,P<0.001)。结论:平喘颗粒能下调小鼠肺组织中TLR4、MyD88和NF-κB的表达水平,进而抑制TLR4/MyD88/NF-κB信号通路的激活,有效缓解CVA小鼠的气道炎症。 展开更多
关键词 TLR4/MyD88/NF-κB信号通路 平喘颗粒 咳嗽变异性哮喘 气道炎症
暂未订购
从“风痰瘀虚”分期治疗咳嗽变异性哮喘经验探析 被引量:1
20
作者 王昊 朱慧志 胡国俊 《中国医药导报》 2025年第7期148-151,共4页
咳嗽变异性哮喘(CVA)通常被认为是一种特殊类型哮喘,常表现为反复发作的刺激性咳嗽。近年来,随着社会环境、生活习惯的变化,该病发病率逐年升高,已引起社会大众广泛的重视。朱慧志教授临证治疗该病颇俱心得,提出“一本三因,分期诊治”... 咳嗽变异性哮喘(CVA)通常被认为是一种特殊类型哮喘,常表现为反复发作的刺激性咳嗽。近年来,随着社会环境、生活习惯的变化,该病发病率逐年升高,已引起社会大众广泛的重视。朱慧志教授临证治疗该病颇俱心得,提出“一本三因,分期诊治”的观点,认为其发病之本在于肺肾阳虚,外感风邪为诱因,伏痰和瘀血为关键病理因素,“风痰瘀虚”内外相合而发病。提出该病发作期以“风痰瘀”为核心,治以祛风通络,止咳化痰为主,兼通鼻窍,予经验方麻旋二虫饮加减;缓解期以“痰瘀虚”为核心,治以补肺温肾,化痰祛瘀,予经验方阳和平喘颗粒加减,临床收效颇丰。本文附治疗CVA医案1则,供临床参考。 展开更多
关键词 咳嗽变异性哮喘 “风痰瘀虚” 麻旋二虫饮 阳和平喘颗粒 名医经验
暂未订购
上一页 1 2 38 下一页 到第
使用帮助 返回顶部